- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
The Massachusetts Department of Public Health (DPH) is expected to announce recipients of medical marijuana dispensary licenses on January 30. About 100 applications were submitted to DPH at the end of November; between 14 and 35 licenses will be issued next week.
Medical marijuana patients are excited that dispensaries are one step closer to opening their doors. Peter Hayashi, a former clinical neuropsychologist and member of the Harvard Medical School Faculty until 2000, has been disabled by severe neuropathic (nerve) pain since 2001. Dr. Hayashi suffers from allodynia, a condition in which normal sensations cause pain. Currently available prescription medications are generally ineffective in this condition.
"I'm excited about this benchmark -- I'm one step closer to having safe access to my medicine. But this progress also means a lot for patients across the nation," said Dr. Hayashi. "The system here in Massachusetts is going to bring legitimacy to the issue because it includes controls like requiring doctors to take educational courses and independent laboratory testing of the medicine. Ultimately this will make the medical community more comfortable with the issue, which in turn will benefit patients."
"I've been impressed with the steps that DPH has taken to execute a transparent process and develop regulations that address concerns from an array of stakeholders," said Matthew J. Allen, Executive Director of the Massachusetts Patient Advocacy Alliance (MPAA). "Given the number of applicants and the thoughtful approach the agency has taken so far, I'm confident that the final pool of licensees will represent those best qualified to meet patient needs."
ASA has been working with MPAA on the implementation of Massachusetts program. MPAA helped bring the medical marijuana ballot initiative to the voters, and has since been working to ensure that patients have a voice in implementation.